西

Suna Kızılyıldırım1, Berfin Sucu2, Muhammed Tilahun Muhammed3

  • 1Cukurova University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Adana, Türkiye.

Heliyon
|March 7, 2025
PubMed
概括

新的胺化合物被选为结核病活性. 化合物7h通过抑制InhA酶表现出有前途的抗结核作用,表明其作为新药候选药物的潜力.